Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

838 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Improved Efficacy of Tafasitamab plus Lenalidomide versus Systemic Therapies for Relapsed/Refractory DLBCL: RE-MIND2, an Observational Retrospective Matched Cohort Study.
Nowakowski GS, Yoon DH, Peters A, Mondello P, Joffe E, Fleury I, Greil R, Ku M, Marks R, Kim K, Zinzani PL, Trotman J, Huang D, Waltl EE, Winderlich M, Kurukulasuriya NC, Ambarkhane S, Hess G, Salles G. Nowakowski GS, et al. Among authors: hess g. Clin Cancer Res. 2022 Jun 8:OF1-OF15. doi: 10.1158/1078-0432.CCR-21-3648. Online ahead of print. Clin Cancer Res. 2022. PMID: 35674661
SNAPSHOT USA 2020: A second coordinated national camera trap survey of the United States during the COVID-19 pandemic.
Kays R, Cove MV, Diaz J, Todd K, Bresnan C, Snider M, Lee TE Jr, Jasper JG, Douglas B, Crupi AP, Weiss KCB, Rowe H, Sprague T, Schipper J, Lepczyk CA, Fantle-Lepczyk JE, Davenport J, Zimova M, Farris Z, Williamson J, Fisher-Reid MC, Rezendes D, King SM, Chrysafis P, Jensen AJ, Jachowski DS, King KC, Herrera DJ, Moore S, van der Merwe M, Lombardi JV, Sergeyev M, Tewes ME, Horan RV 3rd, Rentz MS, Driver A, Brandt LSE, Nagy C, Alexander P, Maher SP, Darracq AK, Barr EG, Hess G, Webb SL, Proctor MD, Vanek JP, Lafferty DJR, Hubbard T, Jiménez JE, McCain C, Favreau J, Fogarty J, Hill J, Hammerich S, Gray M, Rega-Brodsky CC, Durbin C, Flaherty EA, Brooke J, Coster SS, Lathrop RG, Russell K, Bogan DA, Shamon H, Rooney B, Rockhill A, Lonsinger RC, O'Mara MT, Compton JA, Barthelmess EL, Andy KE, Belant JL, Petroelje T, Wehr NH, Beyer DE Jr, Scognamillo DG, Schalk C, Day K, Ellison CN, Ruthven C, Nunley B, Fritts S, Whittier CA, Neiswenter SA, Pelletier R, DeGregorio BA, Kuprewicz EK, Davis ML, Baruzzi C, Lashley MA, McDonald B, Mason D, Risch DR, Allen ML, Whipple LS, Sperry JH, Alexander E, Wolff PJ, Hagen RH, Mortelliti A, Bolinjcar A, Wilson AM, Van Norman S, Powell C, Coletto H, Schauss M, Bontrager H, Beasley J, Ellis-Felege SN, Wehr SR, Giery ST, Pekins CE, LaRose SH, Revord RS, Hansen CP, Hansen L, Millspaugh JJ, Zorn A, Gerber BD, Rezendes K, Adley J, Sevin J, Green AM, Şekercioğlu ÇH, Pendergast ME, Mullen K, Bird T, Edelman AJ, Romero A, O'Neill BJ, Schmitz N, Vandermus RA, Alston JM, Kuhn KM, Hasstedt SC, Lesmeister DB, Appel CL, Rota C, Stenglein JL, Anhalt-Depies C, Nelson CL, Long RA, Remine KR, Jordan MJ, Elbroch LM, Bergman D, Cendejas-Zarelli S, Sager-Fradkin K, Conner M, Morris G, Parsons E, Hernández-Yáñez H, McShea WJ. Kays R, et al. Among authors: hess g. Ecology. 2022 Jun 5:e3775. doi: 10.1002/ecy.3775. Online ahead of print. Ecology. 2022. PMID: 35661139
Genomic analysis of focal nodular hyperplasia with associated hepatocellular carcinoma unveils its malignant potential: a case report.
Ercan C, Coto-Llerena M, Gallon J, Fourie L, Marinucci M, Hess GF, Vosbeck J, Taha-Mehlitz S, Boldanova T, Meier MA, Tzankov A, Matter MS, Hoffmann MHK, Di Tommaso L, von Flüe M, Ng CKY, Heim MH, Soysal SD, Terracciano LM, Kollmar O, Piscuoglio S. Ercan C, et al. Among authors: hess gf. Commun Med (Lond). 2022 Feb 3;2:11. doi: 10.1038/s43856-022-00074-y. eCollection 2022. Commun Med (Lond). 2022. PMID: 35603298 Free PMC article.
Pathogenic or benign?
Du PP, Liu K, Bassik MC, Hess GT. Du PP, et al. Among authors: hess gt. Nat Biotechnol. 2022 Jun;40(6):834-836. doi: 10.1038/s41587-022-01333-y. Nat Biotechnol. 2022. PMID: 35578021 No abstract available.
Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial.
Ferreri AJM, Cwynarski K, Pulczynski E, Fox CP, Schorb E, Celico C, Falautano M, Nonis A, La Rosée P, Binder M, Fabbri A, Ilariucci F, Krampera M, Roth A, Hemmaway C, Johnson PW, Linton KM, Pukrop T, Gørløv JS, Balzarotti M, Hess G, Keller U, Stilgenbauer S, Panse J, Tucci A, Orsucci L, Pisani F, Zanni M, Krause SW, Schmoll HJ, Hertenstein B, Rummel M, Smith J, Thurner L, Cabras G, Pennese E, Ponzoni M, Deckert M, Politi LS, Finke J, Ferranti A, Cozens K, Burger E, Ielmini N, Cavalli F, Zucca E, Illerhaus G; IELSG32 study investigators. Ferreri AJM, et al. Among authors: hess g. Leukemia. 2022 May 13. doi: 10.1038/s41375-022-01582-5. Online ahead of print. Leukemia. 2022. PMID: 35562406
Long-term Outcomes With Ibrutinib Treatment for Patients With Relapsed/Refractory Mantle Cell Lymphoma: A Pooled Analysis of 3 Clinical Trials With Nearly 10 Years of Follow-up.
Dreyling M, Goy A, Hess G, Kahl BS, Hernández-Rivas JÁ, Schuier N, Qi K, Deshpande S, Zhu A, Parisi L, Wang ML. Dreyling M, et al. Among authors: hess g. Hemasphere. 2022 Apr 13;6(5):e712. doi: 10.1097/HS9.0000000000000712. eCollection 2022 May. Hemasphere. 2022. PMID: 35441128 Free PMC article. No abstract available.
Outcome of COVID-19 in Patients With Mantle Cell Lymphoma-Report From the European MCL Registry.
Tilch MK, Visco C, Kinda S, Hermine O, Kohn M, Besson C, Lamure S, Duléry R, Ragaini S, Eyre TA, Van Meerten T, Ohler A, Eckerle S, Dreyling M, Hess G, Giné E, Gomes da Silva M. Tilch MK, et al. Among authors: hess g. Hemasphere. 2022 Apr 8;6(5):e0711. doi: 10.1097/HS9.0000000000000711. eCollection 2022 May. Hemasphere. 2022. PMID: 35425889 Free PMC article.
838 results